GENE - Genetic Technologies Limited

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

Currency in AUD. All numbers in thousands
Total Revenue397.722613.9881,546.368
Cost of Revenue377.71553.284685.013
Gross Profit20.01260.704861.355
Operating Expenses
Research Development1,815.1051,924.6112,191.801
Selling General and Administrative4,472.6924,779.5146,253.02
Non Recurring417.809417.809417.809
Total Operating Expenses---
Operating Income or Loss-6,685.595-6,643.42-7,583.466
Income from Continuing Operations
Total Other Income/Expenses Net263.952366.3721,015.379
Earnings Before Interest and Taxes-6,421.642-6,277.048-6,568.087
Interest Expense24.54221.511203.445
Income Before Tax-6,446.184-6,298.559-6,771.532
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-6,446.184-6,298.559-6,771.532
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-6,446.184-6,298.559-6,771.532
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-6,446.184-6,298.559-6,771.532